Sickle cell disease
Sickle cell disease (homozygous sickle cell anaemia) is a chronic haemolytic anaemia caused by a point mutation in the β-globin gene resulting in substitution of valine for glutamic acid in the sixth position of the β-globin chain. This causes insolubility of Hb S in its deoxygenated state. The insoluble chains crystallize in the red cells causing sickling (Fig. 17.1) and vascular occlusion. The disease is most common in Africans (one in five West Africans are carriers – they have some protection against falciparum malaria). The mutant gene also occurs in other parts of the world where malaria is, or was, prevalent, e.g. the Middle East, Far East and the Indian subcontinent.
Clinical features
These resemble those of other chronic haemolytic anaemias, punctuated with different types of crisis.